Recent FDA Approvals

The U.S. Food and Drug Administration (FDA) has recently approved the following Sublingual tablets for pollen-induced allergies:

Greer's ORALAIR(R), a sublingual immunotherapy tablet for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen specific IgE antibodies for any of the five grass species contained in the product ( Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass). The complete press release from Greer is available here.

Merck's GRASTEK(R), a sublingual immunotherapy tablet for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen specific IgE antibodies for Timothy grass or cross-reactive grass pollens. The complete press release from Merck is available here.

Posted on 4/16/2014 12:00:00 AM